Embolus protection during TAVR
Part of Heart & circulation clinical trials.
This trial tests a new device (EMBLOK EPS) designed to catch debris that might travel to the brain during TAVR heart valve replacement. It compares the device to no protection to see if it is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for a TAVR procedure through the leg (iliofemoral approach).
- You can have an MRI of the brain (no metal clips or non-MRI compatible devices).
- You do not have severe kidney disease (eGFR below 30 or on dialysis).
- You have not had a stroke or mini-stroke in the past 6 months, and no prior stroke with major disability.
- You do not have active infections, bleeding problems, or allergies to the device materials.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device (EmStop) that helps protect your brain during TAVR (a type of heart valve replacement). The device is placed in arteries to catch any debris that might break loose during the procedure, potentially reducing the risk of stroke.
This trial is testing a new device called POINT-GUARD that is used during TAVR (a procedure to replace a heart valve). It aims to see if the device can safely catch any debris or particles that might travel to the brain during the procedure.
This trial studies a device and a technique meant to capture debris during a repeat aortic valve procedure (valve-in-valve TAVR). It may help doctors understand if the approach reduces risk from material that can break loose during the procedure.
This study tests if a special device placed during transcatheter aortic valve replacement (TAVR) can help prevent stroke. It is for adults with severe aortic stenosis who are already scheduled for TAVR.
This trial tests a new filter device designed to catch debris that might travel to the brain during a minimally invasive aortic valve replacement (TAVR). The goal is to see if it can help reduce the risk of stroke.
This trial tests a device that may help protect your brain from small particles during heart valve surgery. It is for people 60 and older having certain types of valve replacement or repair.
Hear when a new Aortic Valve Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.